TRAF3 and plasma cell myeloma: However, although Traf3 has been described as a tumor suppressor and loss of Traf3 was found in a subset of multiple myeloma patients [27, 28], increased levels of TRAF3 in Traf3 transgenic mice also promoted autoimmunity, inflammation, and cancer [29].